On February 1, 2013, the Federal Trade Commission published a proposed rule that would formalize procedures for the withdrawal of merger notifications under the Hart-Scott-Rodino Act. The changes are intended to both codify existing practices, and free up agency resources that would otherwise be spent investigating transactions that are no longer being pursued. But not… Read more »
Earlier this month, the Federal Trade Commission proposed a new set of reporting requirements for the acquisition or transfer of pharmaceutical patents. From the FTC press release: “The Federal Trade Commission is seeking public comments on proposed changes to the premerger notification rules that could require companies in the pharmaceutical industry to report proposed acquisitions… Read more »
On January 24, 2012, the Federal Trade Commission announced its annual revisions to the Hart-Scott-Rodino Act merger notification thresholds. From antitrust lawyers on JD Supra, here’s a look at the new limits: FTC Announces Increased Hart-Scott-Rodino Thresholds (King & Spalding) “As a result of the indexing: The $66 million minimum transaction value filing threshold has increased… Read more »
The Department of Justice and the Federal Trade Commission released their final changes to the Hart-Scott-Rodino reporting form on July 7, 2011. For your reference, here’s what leading law firms are saying about how those changes will affect merger reporting for your company: Antitrust Agencies Announce Final Changes to HSR Filing Form (Reed Smith): “These changes include… Read more »
